Pandemics and Political Behavior in Authoritarian Regimes: Russia and COVID-19

Last registered on April 24, 2020

Pre-Trial

Trial Information

General Information

Title
Pandemics and Political Behavior in Authoritarian Regimes: Russia and COVID-19
RCT ID
AEARCTR-0005755
Initial registration date
April 23, 2020

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
April 24, 2020, 3:04 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Region

Primary Investigator

Affiliation
George Washington University

Other Primary Investigator(s)

Additional Trial Information

Status
In development
Start date
2020-04-24
End date
2020-12-31
Secondary IDs
Abstract
This study consists of three randomized controlled trials (RCTs) designed to improve our understanding of the interaction between a health crisis and political behavior in authoritarian countries. All three are conducted as part of a nationally representative telephone survey of about 1600 adult residents of Russia in April 2020, early in the COVID-19 outbreak. The first RCT investigates three mechanisms through which the coronavirus pandemic might be impacting support for Russia’s president and other leaders. The second RCT investigates how Russian President Putin’s public responses to the pandemic is shaping ordinary people’s behaviors that are widely believed able to influence the spread of the virus. The third RCT considers whether the same leader’s endorsement of health-promoting behavior can increase the likelihood of such behavior.
External Link(s)

Registration Citation

Citation
Hale, Henry. 2020. "Pandemics and Political Behavior in Authoritarian Regimes: Russia and COVID-19." AEA RCT Registry. April 24. https://doi.org/10.1257/rct.5755-1.0
Experimental Details

Interventions

Intervention(s)
The first RCT involves approximately 80% of the sample of 1600 respondents (so approximately N=1280), randomly dividing this 80% into 4 groups of about 320 each. The first group serves as a control and is not asked the first question in the trial at all, while the other three groups each receive a question that asks people to reflect on a different consideration widely linked to the COVID-19 pandemic: intrinsic personal threats linked to the virus’s spread, economic threats associated with the virus crisis, and leaders’ performance in combatting the virus. These three treatment groups are then asked to say how closely they are following news related to the specific threat they are assigned to think about.

The second RCT comes after the first and involves all 1600 respondents in the survey, dividing them randomly into one control group and one treatment group. The treatment group is primed to think about what they believe to be Putin’s position on the coronavirus crisis without being prompted to specify what it is. The control group receives no prime.

The third RCT, which comes after the second RCT in the interview, involves all 1600 respondents and randomly bifurcates the two groups from the second RCT, yielding four groups of about 400 respondents each. Among respondents who were in the second RCT’s control group, one subgroup receives no prime (being a control for the third RCT) and the other subgroup is read a statement from a doctor recommending certain health-related behavior that could curb the spread of the virus. Among respondents who were in the second RCT’s treatment group (those who were asked to reflect on Putin’s position on the virus), one subgroup is read a statement by Vladimir Putin recommending the same kind of health-related behavior that the quoted doctor was recommending that could curb the spread of the virus, while the other subgroup is read both Putin’s and the doctor’s statements.
Intervention Start Date
2020-04-24
Intervention End Date
2020-04-30

Primary Outcomes

Primary Outcomes (end points)
The primary outcomes of interest in the first RCT are four-point agree-disagree scales on three statements of support for Russia’s political leadership. The primary outcomes of interest in the second and third RCTs are 11-point scales on the likelihood the respondent will engage in certain health-related behaviors widely believed capable of curbing the spread of the virus (social isolation).
Primary Outcomes (explanation)
The larger outcome of interest in the first RCT is the difference in patterns of responses between the control group, on the one hand, and the three treatment groups, on the other, and secondarily the difference between the three treatment groups. For the second RCT, the larger outcome of interest is the difference in patterns of answers between the treatment and control groups. For the third RCT, the larger outcome of interest is the difference in patterns of answers between the group receiving both the Putin statement and the doctor’s statement, on one hand, and the group receiving only the doctor’s statement, with the control group providing a measure of baseline opinion without any endorsement. Also of interest will be whether any “rally effect” induced by the virus crisis goes on to shape how people respond to a health-behavior endorsement from the leader potentially benefiting from the rally. The larger outcome of interest here will be the degree of effect heterogeneity in the second and third RCTs observed across the groups from the first RCT.

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
The experiment (full text attached to this registry) is embedded in the regular “omnibus” survey of Russia’s highly reputable Levada-Center agency. The sample is selected through a probability sampling method with random digit dialing (RDD) to generate mobile phone numbers within the fixed range of prefixes and numbers functional in Russia proportionally to each federal district. The total coverage of the target population is 97 percent by the mobile frame sample. No socio-demographic quotas are used. It will include about 1600 residents of Russia age 18 or older. Interviews will be conducted by phone using the CATI method.
Experimental Design Details
Randomization Method
Randomization in the assignment of respondents to control and treatment groups is achieved through the randomization function in Levada’s survey software.
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
0
Sample size: planned number of observations
1600 adult residents of Russia
Sample size (or number of clusters) by treatment arms
For the first RCT, there will be approximately 320 in the control group and 320 in each of the three treatment groups. For the second RCT, there will be approximately 800 in the control group and 800 in the treatment group. For the third RCT, there will be approximately 400 in the control group and 400 in each of the three treatment groups.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
George Washington University
IRB Approval Date
2020-04-22
IRB Approval Number
NCR031629
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials